The antiviral drug ensitrelvir eases both smell and taste loss, and is one of the few COVID-19 drugs available to people not at high risk of grave illness.

New clinical-trial data suggest that an antiviral pill called ensitrelvir shortens the duration of two unpleasant symptoms of COVID-19: loss of smell and taste. The medication is among the first to alleviate these effects and, unlike other COVID-19 treatments, is not reserved only for people at high risk of severe illness.

  • GroteStreet 🦘@aussie.zoneEnglish
    2·
    1 year ago

    Ah. So the article that - after mentioning all the other scary stuff like ebola and HIV - concluded with 10 paragraphs basically saying how sars-cov-2 is quite dissimilar to them? How most other coronavirus infections are short-lived?

    Or, “Covid-19 long-haulers are probably not dealing with the virus for months on end. Rather, … that the immune system is trying to repair the damage”.

    The one that ends with the quote that, for the majority of people, "It gets in, it gets out”?